Pulmonary toxicity secondary to procarbazine

Tallat Mahmood, Raja Mudad

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Procarbazine is a chemotherapy methylating agent that has been used in combination with other drugs, perhaps most successfully in the treatment of Hodgkin's disease. There are several side effects that it is commonly associated with; however, it has only rarely been reported to cause lung injury. The resulting pneumonitis may be severe and irreversible. There are eight reported cases in the literature. Here, we report another such case.

Original languageEnglish (US)
Pages (from-to)187-188
Number of pages2
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume25
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Procarbazine
Lung Injury
Hodgkin Disease
Pneumonia
Drug Therapy
Lung
Pharmaceutical Preparations
Therapeutics

Keywords

  • Lung injury
  • Procarbazine

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Pulmonary toxicity secondary to procarbazine. / Mahmood, Tallat; Mudad, Raja.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, No. 2, 2002, p. 187-188.

Research output: Contribution to journalArticle

@article{c8d92aadbe044675a302587f0295e2b5,
title = "Pulmonary toxicity secondary to procarbazine",
abstract = "Procarbazine is a chemotherapy methylating agent that has been used in combination with other drugs, perhaps most successfully in the treatment of Hodgkin's disease. There are several side effects that it is commonly associated with; however, it has only rarely been reported to cause lung injury. The resulting pneumonitis may be severe and irreversible. There are eight reported cases in the literature. Here, we report another such case.",
keywords = "Lung injury, Procarbazine",
author = "Tallat Mahmood and Raja Mudad",
year = "2002",
doi = "10.1097/00000421-200204000-00018",
language = "English (US)",
volume = "25",
pages = "187--188",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Pulmonary toxicity secondary to procarbazine

AU - Mahmood, Tallat

AU - Mudad, Raja

PY - 2002

Y1 - 2002

N2 - Procarbazine is a chemotherapy methylating agent that has been used in combination with other drugs, perhaps most successfully in the treatment of Hodgkin's disease. There are several side effects that it is commonly associated with; however, it has only rarely been reported to cause lung injury. The resulting pneumonitis may be severe and irreversible. There are eight reported cases in the literature. Here, we report another such case.

AB - Procarbazine is a chemotherapy methylating agent that has been used in combination with other drugs, perhaps most successfully in the treatment of Hodgkin's disease. There are several side effects that it is commonly associated with; however, it has only rarely been reported to cause lung injury. The resulting pneumonitis may be severe and irreversible. There are eight reported cases in the literature. Here, we report another such case.

KW - Lung injury

KW - Procarbazine

UR - http://www.scopus.com/inward/record.url?scp=0036221166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036221166&partnerID=8YFLogxK

U2 - 10.1097/00000421-200204000-00018

DO - 10.1097/00000421-200204000-00018

M3 - Article

C2 - 11943900

AN - SCOPUS:0036221166

VL - 25

SP - 187

EP - 188

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 2

ER -